clenbuterol has been researched along with Chronic Lung Injury in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henriquez, AR | 1 |
| Snow, SJ | 1 |
| Schladweiler, MC | 1 |
| Miller, CN | 1 |
| Dye, JA | 1 |
| Ledbetter, AD | 1 |
| Richards, JE | 1 |
| Hargrove, MM | 1 |
| Williams, WC | 1 |
| Kodavanti, UP | 1 |
1 other study available for clenbuterol and Chronic Lung Injury
| Article | Year |
|---|---|
Beta-2 Adrenergic and Glucocorticoid Receptor Agonists Modulate Ozone-Induced Pulmonary Protein Leakage and Inflammation in Healthy and Adrenalectomized Rats.
Topics: Adrenalectomy; Adrenergic beta-2 Receptor Agonists; Animals; Bronchoalveolar Lavage Fluid; Clenbuter | 2018 |